Showing results (51-60 of 365) with videos related to

Sort By:
Pageof 37
The Journal of Nutrition, Health & Aging|March 26, 2005
Long-term cholinergic treatment is not associated with greater risk of weight loss during Alzheimer's disease: data from the French REAL.FR cohortS Gillette-Guyonnet, F Cortes, C Cantet, et al.
Psychopharmacology|May 18, 1999
Divided attention-enhancing effects of AF102B and THA in aging monkeysJ O'Neill, L J Fitten, D W Siembieda, et al.
Physiology & Behavior|September 9, 2000
Effects of muscarinic and adrenergic agonism on auditory P300 in the macaqueJ O'Neill, E Halgren, K Marinkovic, et al.
Current Medical Research and Opinion|July 4, 2002
Efficacy and safety of rivastigmine in patients with Alzheimer's disease who failed to benefit from treatment with donepezilS Auriacombe, J J Pere, Y Loria-Kanza, et al.
The Journal of Nutrition, Health & Aging|January 27, 2011
Progress in the development of new drugs in Alzheimer's diseaseAntoine Piau, F Nourhashémi, C Hein, et al.
Neurology|October 28, 2009
Diabetes is associated with a slower rate of cognitive decline in Alzheimer diseaseC Sanz, S Andrieu, A Sinclair, et al.
The Journal of Nutrition, Health & Aging|January 31, 2019
Is Fat Mass Cross-Sectionally Associated with Cortical Aβ Load in the Human Brain?M Maltais, P de Souto Barreto, Y Rolland, et al.
The Journal of Nutrition, Health & Aging|March 24, 2006
Disease modifying trials in Alzheimer disease: methodological and statistical issuesS Andrieu, O Rascol, T Lang, et al.
The Journal of Prevention of Alzheimer'S Disease|May 8, 2019
Advancing Alzheimer's Disease Treatment: Lessons from CTAD 2018B Vellas, L J Bain, J Touchon, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|November 1, 1995
Techniques of assessing muscle mass and function (sarcopenia) for epidemiological studies of the elderlyW C Chumlea, S S Guo, B Vellas, et al.
Pageof 37